<DOC>
	<DOCNO>NCT02048761</DOCNO>
	<brief_summary>This study design randomize , control clinical trial evaluate efficacy 1 % MF gel local drug delivery adjunct SRP treatment intrabony defect chronic periodontitis comparison placebo gel .</brief_summary>
	<brief_title>Locally Delivered 1 % Metformin Gel Treatment Intrabony Defects Chronic Periodontitis</brief_title>
	<detailed_description>Background : Metformin ( MF ) belong class biguanide , first-line therapy type 2 diabetes mellitus , one commonly prescribed oral hypoglycemic drug worldwide . MF show posses bone form bone spar action . The present study design investigate effectiveness MF , 1 % indigenously prepared biodegradable controlled-release gel , adjunct scale root planing ( SRP ) treatment chronic periodontitis subject intrabony defect . Materials Methods : Sixty five subject categorize two treatment group : SRP plus 1 % MF SRP plus placebo . Clinical parameter record baseline 3 6 month ; include plaque index ( PI ) , modify sulcus bleed index ( mSBI ) , probe depth ( PD ) , clinical attachment level ( CAL ) . At baseline 6 month , radiologic assessment intrabony defect ( IBD ) fill do use computer-aided software .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Systemically healthy subject Sites probe depth ( PD ) ≥5 mm Clinical attachment level ( CAL ) ≥4 mm Vertical bone loss ≥3 mm intraoral periapical radiograph history periodontal therapy use antibiotic precede 6 month include Patients know systemic disease Known suspect allergy MF/ biguanide group Patients systemic MF oral antidiabetic therapy Patients aggressive periodontitis Patients diabetes Use tobacco form Alcoholism Immunocompromised patient Pregnant lactating female</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>